Skip to main content
. 2017 Nov 15;11(2):182–188. doi: 10.1111/cts.12520

Figure 6.

Figure 6

Clinical development strategies for drugs with new active ingredients in general global clinical trials (GCTs) and Asian GCTs. (A) The ratios of source data for the ethnic comparisons of the pharmacokinetics (PK) in the general GCTs and Asian GCTs are shown. The PK data had been collected from two sources, standard PK early‐phase studies or the late‐phase studies such as GCTs. (B) The performance ratios of exploratory trials for the Japanese population including clinical pharmacology studies in the general GCTs and Asian GCTs are shown.